AU Patent

AU2023237067A1 — Pyridyl inhibitors of hedgehog signalling

Assigned to Genentech Inc · Expires 2023-10-12 · 3y expired

What this patent protects

ABS]RACG The invention provides novel inhibitors of hedgehog signaling that are useful as a therapeutic agents for treating malignancies where the compounds have the general formula 1 (R 3) K$X R N Y e A (R2)n wherein A, X, Y RI, R2, R(,, R4, m and n are as described herein…

USPTO Abstract

ABS]RACG The invention provides novel inhibitors of hedgehog signaling that are useful as a therapeutic agents for treating malignancies where the compounds have the general formula 1 (R 3) K$X R N Y e A (R2)n wherein A, X, Y RI, R2, R(,, R4, m and n are as described herein,

Drugs covered by this patent

Patent Metadata

Patent number
AU2023237067A1
Jurisdiction
AU
Classification
—
Expires
2023-10-12
Drug substance claim
No
Drug product claim
No
Assignee
Genentech Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.